ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.
ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.
Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
The placebo effect in clinical trials of the mental disorder has increased over the past decade.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.
Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
How plants pass defenses to offspring through a complex molecular network